Zoetis Inc. (ZTS) is the 7th largest of 86 Animal Health companies by market capitalisation, at 30.60 Bn, behind Idexx Laboratories Inc /De at 40.78 Bn. It trades on a P/E of 9.35, 68% below the peer median of 29.50. The table below compares all 86 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IDXX | Idexx Laboratories Inc /De | primary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 40.78 Bn | 35.78 | 8.96 | 40.58 Bn |
| 2 | ZTS | Zoetis Inc. | primary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 30.60 Bn | 9.35 | 3.22 | 28.93 Bn |
| 3 | ELAN | Elanco Animal Health Inc | primary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 11.84 Bn | -59.50 | 2.36 | 11.31 Bn |
| 4 | PAHC | Phibro Animal Health Corp | primary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | 14.97 | 0.98 | 1.41 Bn |
| 5 | ICCC | Immucell Corp /De/ | primary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | -211.68 | 3.36 | 0.08 Bn |
| 6 | ZYBT | Zhengye Biotechnology Holding Ltd | primary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -8.90 | 4.59 | 0.07 Bn |
| 7 | GIPL | Global Innovative Platforms Inc. | primary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -36.02 | 132.88 | 0.02 Bn |
| 8 | MRK | Merck & Co., Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 366.10 Bn | 115.53 | 5.50 | 358.96 Bn |
| 9 | TMO | Thermo Fisher Scientific Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 224.59 Bn | 31.90 | 4.85 | 220.52 Bn |
| 10 | PFE | Pfizer Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 159.23 Bn | 36.45 | 2.50 | 147.53 Bn |
| 11 | COR | Cencora, Inc. | secondary | H-19 | Healthcare Payers and Distributors | HG-05 | 62.90 Bn | 23.83 | 0.19 | 60.08 Bn |
| 12 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.77 Bn | 61.46 | 2.47 | 39.12 Bn |
| 13 | WST | West Pharmaceutical Services Inc | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 23.95 Bn | 43.60 | 7.20 | 23.52 Bn |
| 14 | IFF | International Flavors & Fragrances Inc | secondary | M-02 | Chemicals | MG-01 | 21.54 Bn | 73.78 | 2.16 | 20.97 Bn |
| 15 | STE | STERIS plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 21.11 Bn | 26.12 | 3.50 | 20.63 Bn |
| 16 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.13 Bn | -46.58 | 1.30 | 18.24 Bn |
| 17 | CRL | Charles River Laboratories International, Inc. | secondary | H-11 | Pharma Services | HG-03 | 13.31 Bn | -55.99 | 3.33 | 13.12 Bn |
| 18 | RDY | Dr Reddys Laboratories Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 9.86 Bn | 781.18 | 2.69 | 9.68 Bn |
| 19 | PODD | Insulet Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 9.84 Bn | 26.22 | 3.22 | 9.31 Bn |
| 20 | IONS | Ionis Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 9.31 Bn | -43.85 | 10.65 | 7.25 Bn |
| 21 | CHWY | Chewy, Inc. | secondary | S-04 | Branded Foods | SG-02 | 8.75 Bn | 34.29 | 0.68 | 8.23 Bn |
| 22 | ALKS | Alkermes plc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.60 Bn | 114.89 | 4.56 | 6.94 Bn |
| 23 | GIFLF | Grifols SA | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.54 Bn | 29.70 | 0.46 | 9.09 Bn |
| 24 | LNTH | Lantheus Holdings, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 6.58 Bn | 23.90 | 4.23 | 5.99 Bn |
| 25 | LQDA | Liquidia Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.08 Bn | 43.86 | 13.48 | 5.79 Bn |
| 26 | LGND | Ligand Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.82 Bn | 29.50 | 20.03 | 4.46 Bn |
| 27 | TLPPF | Telix Pharmaceuticals Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.89 Bn | -521.64 | 4.64 | 3.59 Bn |
| 28 | OGN | Organon & Co. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.61 Bn | 17.25 | 0.59 | 2.47 Bn |
| 29 | NEOG | Neogen Corp | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 2.58 Bn | -364.03 | 2.96 | 2.39 Bn |
| 30 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.36 Bn | -2.16 | 0.22 | 0.53 Bn |
| 31 | ADMA | Adma Biologics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.14 Bn | 12.86 | 4.18 | 2.00 Bn |
| 32 | BFLY | Butterfly Network, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 1.98 Bn | -26.46 | 17.66 | 1.85 Bn |
| 33 | NVAX | Novavax Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.62 Bn | -6.56 | 3.93 | 0.90 Bn |
| 34 | SCNI | Scinai Immunotherapeutics Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.61 Bn | -191.78 | 932.86 | 1.60 Bn |
| 35 | IART | Integra Lifesciences Holdings Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 1.24 Bn | -171.38 | 0.75 | 0.97 Bn |
| 36 | MGTX | MeiraGTx Holdings plc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.23 Bn | 7.48 | 3.08 | 1.09 Bn |
| 37 | MRVI | Maravai Lifesciences Holdings, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.03 Bn | -7.58 | 4.94 | 0.96 Bn |
| 38 | AMPH | Amphastar Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.99 Bn | 11.90 | 1.36 | 0.70 Bn |
| 39 | LXRX | Lexicon Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.94 Bn | -15.00 | 22.74 | 0.75 Bn |
| 40 | QDEL | QuidelOrtho Corp | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.88 Bn | — | — | 0.76 Bn |
| 41 | AVR | Anteris Technologies Global Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.84 Bn | -10.06 | 372.95 | 0.84 Bn |
| 42 | EVO | Evotec SE | secondary | H-11 | Pharma Services | HG-03 | 0.65 Bn | — | — | 0.22 Bn |
| 43 | AQST | Aquestive Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | -8.11 | 11.73 | 0.54 Bn |
| 44 | RGNX | REGENXBIO Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -2.66 | 2.49 | 0.37 Bn |
| 45 | EYPT | EyePoint, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.39 Bn | -1.27 | 141.03 | 0.21 Bn |
| 46 | STRO | Sutro Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.31 Bn | -2.70 | 3.42 | 0.14 Bn |
| 47 | EMBC | Embecta Corp. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.30 Bn | 3.47 | 0.30 | 0.09 Bn |
| 48 | EBS | Emergent BioSolutions Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -1.66 | 0.38 | 0.15 Bn |
| 49 | ANIK | Anika Therapeutics, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.28 Bn | -131.23 | 2.31 | 0.24 Bn |
| 50 | MGNX | Macrogenics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -16.06 | 1.54 | 0.14 Bn |
| 51 | OSUR | Orasure Technologies Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.25 Bn | — | 2,463.89 | 0.05 Bn |
| 52 | UTMD | Utah Medical Products Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.22 Bn | 22.54 | 6.16 | 0.14 Bn |
| 53 | APYX | Apyx Medical Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -15.31 | 2.26 | 0.10 Bn |
| 54 | CDXS | Codexis, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -4.25 | 1.68 | 0.08 Bn |
| 55 | VANI | Vivani Medical, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.12 Bn | -4.27 | — | 0.10 Bn |
| 56 | PTHS | Pelthos Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | -0.76 | 1.56 | 0.06 Bn |
| 57 | NTRB | NutriBand Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -10.28 | 44.26 | 0.07 Bn |
| 58 | XBIT | XBiotech Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -1.61 | — | 0.07 Bn |
| 59 | HYFT | MindWalk Holdings Corp. | secondary | H-11 | Pharma Services | HG-03 | 0.06 Bn | -5.75 | 5.27 | 0.05 Bn |
| 60 | CELU | Celularity Inc | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.41 | 1.43 | 0.03 Bn |
| 61 | SCLX | Scilex Holding Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.08 | 1.17 | -0.08 Bn |
| 62 | NSYS | Nortech Systems Inc | secondary | I-04 | Machinery | IG-02 | 0.03 Bn | 12.07 | 0.37 | 0.03 Bn |
| 63 | BHST | Bioharvest Sciences Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.09 | 0.93 | 0.02 Bn |
| 64 | LASE | Laser Photonics Corp | secondary | I-04 | Machinery | IG-02 | 0.03 Bn | -0.89 | 5.26 | 0.03 Bn |
| 65 | ABVC | Abvc Biopharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.72 | — | 0.03 Bn |
| 66 | GNVR | Genvor Inc | secondary | M-05 | Chemicals | MG-01 | 0.03 Bn | -7.21 | — | 0.02 Bn |
| 67 | RDGL | Vivos Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | -8.86 | 399.68 | 0.02 Bn |
| 68 | LGVN | Longeveron Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.89 | 17.63 | 0.01 Bn |
| 69 | CTSO | Cytosorbents Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.02 Bn | -1.12 | 0.55 | 0.02 Bn |
| 70 | COSM | Cosmos Health Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.79 | 0.22 | 0.01 Bn |
| 71 | ALRTF | ALR Technologies SG Ltd. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -0.55 | — | 0.01 Bn |
| 72 | NAII | Natural Alternatives International Inc | secondary | H-12 | Pharma Services | HG-03 | 0.01 Bn | -0.86 | 0.09 | 0.00 Bn |
| 73 | PLUR | Pluri Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.00 | 8.64 | 0.00 Bn |
| 74 | AIMD | Ainos, Inc. | secondary | T-15 | Computer Hardware | TG-02 | 0.01 Bn | -0.77 | 816.86 | 0.01 Bn |
| 75 | DQWS | DSwiss Inc | secondary | S-11 | Household and Personal Products | SG-05 | 0.01 Bn | -27.32 | 4.18 | 0.01 Bn |
| 76 | GELS | Gelteq Ltd | secondary | H-12 | Pharma Services | HG-03 | 0.01 Bn | — | — | 0.01 Bn |
| 77 | AIDX | 20/20 Biolabs, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 0.01 Bn | -0.94 | 2.80 | 0.00 Bn |
| 78 | SNOA | Sonoma Pharmaceuticals, Inc. | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -2.26 | 0.23 | 0.00 Bn |
| 79 | CLGN | CollPlant Biotechnologies Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.64 | 10.92 | 0.00 Bn |
| 80 | CANF | Can-Fite BioPharma Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.24 | 5.93 | 0.00 Bn |
| 81 | VNRX | Volitionrx Ltd | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.09 | 0.62 | 0.00 Bn |
| 82 | VRAX | Virax Biolabs Group Ltd | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.19 | 84.17 | -0.01 Bn |
| 83 | SKVI | Skinvisible, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.05 | 54.04 | 0.00 Bn |
| 84 | CDT | CDT Equity Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | — | 0.00 Bn |
| 85 | JAGX | Jaguar Health, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.01 | 0.01 | -0.01 Bn |
| 86 | NXGLW | Nexgel, Inc. | secondary | H-12 | Pharma Services | HG-03 | 0.00 Bn | -0.02 | 0.01 | 0.00 Bn |